Search results
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 3 days agoIn the briefing document, the FDA staff gave a brief history of coronavirus vaccines, noting that...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
Reuters via AOL· 16 hours ago(Reuters) -Advisers to the U.S. Food and Drug Administration on Wednesday unanimously voted in favor...
Why Is Novavax (NVAX) Stock Up 20% Today?
InvestorPlace· 9 hours agoNovavax (NASDAQ:NVAX) is on a recovery trek after collapsing in late 2021. Regarding timeline, the latter two firms said that they would be able to...
NHS launches personalised mRNA cancer vaccines trial
Clinical Trials Arena via Yahoo Finance· 6 days agoThe company will present preliminary data, highlighting the potential of circulating tumour DNA in the early detection of colorectal cancer. The vaccine...
FDA advisers: Next COVID shots should target variants with JN.1 lineage | Honolulu Star-Advertiser
Honolulu Star-Advertiser· 19 hours agoAdvisers to the U.S. Food and Drug Administration today unanimously voted in favor of recommending...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say By...
Investing.com· 16 hours agoCOVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 1 day agoOn Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE: MRK) also reported durable efficiency of...
What's Going On With Novavax Stock? - Novavax (NASDAQ:NVAX)
Benzinga· 12 hours agoNovavax, Inc. NVAX shares are trading higher Wednesday, and the stock is up by more than 300% over...
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
Reuters· 3 days agoVaccine makers should consider targeting one of the currently dominant JN.1 variants and...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 6 days agoThe FDA recently delayed its decision on the Moderna vaccine to the end of the month. If approved,...